Orchestration of Vegf-Activated Erk2/1 Signaling Module in Caveolae: Role of Caveolin-1 in Placental Artery Endothelial Cell Migration

Wu Xiang Liao,Honghai Zhang,Lin Feng,Jing Zheng,Dongbao Chen
DOI: https://doi.org/10.1093/biolreprod/78.s1.294b
2008-01-01
Biology of Reproduction
Abstract:Caveolin-1 (Cav1) is the principal residual protein of the plasmalemmal microdomains termed as caveolae that are most abundant in terminally differentiation cell types including endothelial cells (EC). Caveoli functions as a platform for organizing multiple signaling modules that participate in angiogenic responses such as EC proliferation and migration. We have previously shown that the primary placental angiogenic promoter VEGF stimulates ovine fetoplacental artery endothelial (oFPAE) cell proliferation partially via ERK2/1 activation. However, it is not known if Cav1/caveolae plays a role in the VEGF-induced ERK2/1 activation and placental angiogenic responses. We hypothesize that: 1) VEGF-activated cell migration is depended on ERK2/1 signaling pathway; 2) VEGF-activated ERK2/1 signaling pathway is compartmentalized in the caveolae and disruption of caveolae interferes VEGF-induced ERK2/1 activation and; 3) Caveolae/Cav1 regulates VEGF stimulated ERK2/1 phosphorylation and cell migration. Ovine fetoplacental artery EC (oFPAEC) and its transformed counterpart, SV40-OF cell line, were cultured in MCDB-131/10% FBS/antibiotics. Serum-starved subconfluent (80%) cells were treated with rhVEGF (0 to 100 ng/ml) for various times. Disruption of caveolae was achieved by treatment with β-cyclodextrin (β-CD, 10 mM) for 1h, which was confirmed by transmission electron microscopy. Overexpression of Cav1 was achieved by transfection of adenovirus expression vector carrying full-length Cav1 cDNA or incubation with Cav1 scaffolding domain peptide (Cav-SD, 5 μM) for 2h. SV40-OF cells were used for fractionation of caveolae membranes by discontinuous sucrose gradient (45%/35%/5%) ultracentrifugation. Activation of ERK2/1 signaling pathway were analyzed by immunoblotting with specific antibodies. oFPAE cell migration was determined by BD transwell migration assay. VEGF dose- and time- dependently stimulated ERK2/1 phosphorylation in intact oFPAE and SV40-OF cells, which was abrogated by pretreatments with β-CD or Cav-SD and adenoviral overexpression of Cav1. All the molecules for compromising the ERK2/1 signaling module, PLCγ, PKCα, Src, Ras, Raf-1, MEK2/1 and ERK2/1, were detectable in purified caveolae membranes positive for various markers including caveolin-1, eNOS, flotillin-1, and β-adaptin. In caveolae, VEGF dramatically increased phosphorylated ERK2/1 without altering total ERK2/1 in a time-dependent manner similar to that in intact cells. Pretreatments with β-CD, Cav-SD or overexpression of Cav1 blocked VEGF stimulation of ERK2/1 phosphorylation in caveolae. VEGF significantly stimulated oFPAE cell migration. In the presence of PD98059 (20 μM), the VEGF-induced oFPAE cell migration was attenuated. Pretreatments with β-CD and Cav-SD as well as overexpression of Cav1 also significantly inhibited VEGF-induced oFPAE cell migration. Thus, we conclude that through Cav1 caveolae serves as a platform for compartmentalizing the VEGF-induced ERK2/1 signaling pathway that plays a critical role in placental endothelial cell migration (Supported by NIH RO1 grants HL74947 & HL70562 to DBC & HL64703 to JZ)
What problem does this paper attempt to address?